Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Disease, Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00078546
What this trial is testing

EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC)

Who this might be right for
Nasopharyngeal CancerEBV Infections
Baylor College of Medicine 12
Not applicableStudy completedNCT02198131
What this trial is testing

Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia

Who this might be right for
Oral Complications of Radiation TherapyStage I Laryngeal CancerStage II Laryngeal Cancer
Wake Forest University Health Sciences 9
Not applicableWithdrawnNCT04922112
What this trial is testing

Sleep Apnea in Head and Neck Cancer Patients at the University of Colorado

Who this might be right for
Obstructive Sleep ApneaSquamous Cell Carcinoma of Head and Neck
University of Colorado, Denver
Testing effectiveness (Phase 2)Looking for participantsNCT06385730
What this trial is testing

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 60
Not applicableActive Not RecruitingNCT03306901
What this trial is testing

Chemoradiotherapy Versus Esophagectomy After Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Samsung Medical Center 240
Testing effectiveness (Phase 2)Study completedNCT00447330
What this trial is testing

Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma

Who this might be right for
Esophageal NeoplasmsStomach NeoplasmsNeoplasm Metastasis
Duke University 60
Not applicableStudy completedNCT04656392
What this trial is testing

Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary Care

Who this might be right for
Barrett EsophagusEsophageal Cancer
Radboud University Medical Center 449
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07129772
What this trial is testing

Perioperative Chemotherapy and Immunotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer RecurrentNasopharyngeal Cancinoma (NPC)
The University of Hong Kong 53
Not applicableTemporarily pausedNCT07268092
What this trial is testing

Porcine Extracellular Matrix Nerve Wrap in Neck Dissection for Head and Neck Cancer

Who this might be right for
Head and Neck CancerNeck DissectionPostoperative Complications
Henry Ford Health System 74
Not applicableNot Yet RecruitingNCT07642492
What this trial is testing

REcovery After Cancer Application

Who this might be right for
Oesophageal CancerGastric Cancer (Diagnosis)
Karolinska Institutet 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT03174275
What this trial is testing

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

Who this might be right for
Carcinoma, Squamous CellOral CancerOropharynx Cancer+3 more
UNC Lineberger Comprehensive Cancer Center 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05484375
What this trial is testing

Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma After First-line Treatment

Who this might be right for
Metastatic Nasopharyngeal Carcinoma
Affiliated Cancer Hospital & Institute of Guangzhou Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Early research (Phase 1)Study completedNCT01036412
What this trial is testing

Chlorhexidine Gel Therapy for Cariogenic Oral Microflora

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00697619
What this trial is testing

To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer

Who this might be right for
Nasopharyngeal Cancer
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07367516
What this trial is testing

Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 105
Testing effectiveness (Phase 2)Study completedNCT00462735
What this trial is testing

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerCancer of the PharynxCancer of the Larynx+3 more
Johnny Kao 33
Testing effectiveness (Phase 2)Study completedNCT03389295
What this trial is testing

Reduced Target Delineation and Radiation Doses Chemoradiotherapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Xiayun He, MD 118
Not applicableLooking for participantsNCT04688801
What this trial is testing

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

Who this might be right for
Esophageal CancerGastroesophageal CancerImmunotherapy+1 more
The Second Hospital of Shandong University 200
Testing effectiveness (Phase 2)Ended earlyNCT02540928
What this trial is testing

AMG 319 in HPV Positive and Negative HNSCC

Who this might be right for
Human Papillomavirus (HPV)Positive or Negative Head and Neck Squamous Cell Carcinoma (HNSCC) of the Hypopharynx, Oropharynx, Oral Cavity, Supraglottis or Larynx
Cancer Research UK 35
Next Page